Back
Pacira BioSciences Stock Price Chart
Sponsored
PCRX
Sponsored
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Buy
53
PCRX
Pacira BioSciences
Last Price:
$20.61
Seasonality Move:
6.99%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing slight selling pressure.
Pacira BioSciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.88 | Buy |
20-day SMA: | 19.33 | Buy |
50-day SMA: | 18.14 | Buy |
200-day SMA: | 21.12 | Sell |
8-day EMA: | 19.18 | Buy |
20-day EMA: | 19.01 | Buy |
50-day EMA: | 18.35 | Buy |
200-day EMA: | 21.04 | Sell |
Pacira BioSciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 65.27 | Buy |
Chaikin Money Flow: | -581249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.71 - 19.89) | Buy |
Bollinger Bands (100): | (14.58 - 18.62) | Buy |
Pacira BioSciences Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pacira BioSciences Stock
Is Pacira BioSciences Stock a Buy?
-
Pacira BioSciences share price is 20.64 while PCRX 8-day simple moving average is 18.88, which is a Buy signal.
-
The stock price of PCRX is 20.64 while Pacira BioSciences 20-day SMA is 19.33, which makes it a Buy.
-
Pacira BioSciences 50-day simple moving average is 18.14 while PCRX share price is 20.64, making it a Buy technically.
-
PCRX stock price is 20.64 and Pacira BioSciences 200-day simple moving average is 21.12, creating a Sell signal.
PCRX Technical Analysis vs Fundamental Analysis
Buy
53
Pacira BioSciences (PCRX)
is a Buy
Is Pacira BioSciences a Buy or a Sell?
-
Pacira BioSciences stock is rated a BuyThe current Pacira BioSciences [PCRX] share price is $20.64. The Score for PCRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Pacira BioSciences Stock Info
Market Cap:
953M
Price in USD:
20.64
Share Volume:
1.7M
Pacira BioSciences 52-Week Range
52-Week High:
34.01
52-Week Low:
11.16
Buy
53
Pacira BioSciences (PCRX)
is a Buy
Pacira BioSciences Share Price Forecast
-
What is the Pacira BioSciences stock price today?The Pacira BioSciences stock price is 20.64 USD today.
-
Will PCRX stock go up or go down?Pacira BioSciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Pacira BioSciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pacira BioSciences is not overvalued.
Is Pacira BioSciences Stock a Buy?
-
Pacira BioSciences share price is 20.64 while PCRX 8-day exponential moving average is 19.18, which is a Buy signal.
-
The stock price of PCRX is 20.64 while Pacira BioSciences 20-day EMA is 19.01, which makes it a Buy.
-
Pacira BioSciences 50-day exponential moving average is 18.35 while PCRX share price is 20.64, making it a Buy technically.
-
PCRX stock price is 20.64 and Pacira BioSciences 200-day simple moving average is 21.04, creating a Sell signal.
Fundamental Analysis of Pacira BioSciences
Is Pacira BioSciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.21 per share.
Technical Analysis of Pacira BioSciences
Should I short Pacira BioSciences stock?
-
PCRX Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Pacira BioSciences is a Buy
-
Pacira BioSciences Relative Strength Index (RSI) is 65.27, which suggest Pacira BioSciences is overbought
-
The Bollinger Bands (25) for Pacira BioSciences is (18.71 - 19.89), which suggest Pacira BioSciences is a Buy
-
The Bollinger Bands (100) for Pacira BioSciences is (14.58 - 18.62), which suggest Pacira BioSciences is a Buy
* Pacira BioSciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.